131 related articles for article (PubMed ID: 19204912)
1. Ultrasound increases DNA damage attributable to cisplatin in cisplatin-resistant human ovarian cancer cells.
Yu T; Yang Y; Liu S; Yu H
Ultrasound Obstet Gynecol; 2009 Mar; 33(3):355-9. PubMed ID: 19204912
[TBL] [Abstract][Full Text] [Related]
2. [Expression of DNA transcription- and repair-related genes in cisplatin-resistant human ovarian carcinoma cell line COC1/DDP].
Cao MM; Zhang JR; Wang SM; Hu XG; Hu LJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1478-81. PubMed ID: 16354609
[TBL] [Abstract][Full Text] [Related]
3. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
4. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
Zhou Y; Chen H; Yang Q
Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):680-3. PubMed ID: 9275551
[TBL] [Abstract][Full Text] [Related]
5. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.
Yu T; Yang Y; Zhang J; He H; Ren X
Eur J Pharm Biopharm; 2015 Apr; 91():103-10. PubMed ID: 25668779
[TBL] [Abstract][Full Text] [Related]
6. [Study of ceramide monohexoside in ovarian cell line COC1/DDP resistant to cisplantin].
Qin TN; Wang LL; Chen HG; Gao QH; Zhou RX; Sun BZ; Wang QW
Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):556-9. PubMed ID: 14680612
[TBL] [Abstract][Full Text] [Related]
7. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
Chen G; Zeller WJ; Todorov DK
Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D
Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between expression of apoptosis-associated proteins and caspase-3 activity in cisplatin-resistant human ovarian cancer cell line].
Yang XK; Zheng F; Chen JH; Gao QL; Lu YP; Wang SX; Wang CY; Ma D
Ai Zheng; 2002 Dec; 21(12):1288-91. PubMed ID: 12520732
[TBL] [Abstract][Full Text] [Related]
10. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
[TBL] [Abstract][Full Text] [Related]
11. Biological effects of ultrasound exposure on adriamycin-resistant and cisplatin-resistant human ovarian carcinoma cell lines in vitro.
Yu T; Bai J; Hu K; Wang Z
Ultrason Sonochem; 2004 Apr; 11(2):89-94. PubMed ID: 15030785
[TBL] [Abstract][Full Text] [Related]
12. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines].
Yang X; Zheng F; Xing H; Gao Q; Wang W; Lu Y; Wang S; Ma D
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):544-7. PubMed ID: 12667321
[TBL] [Abstract][Full Text] [Related]
14. Detection of DNA damage in sonochemotherapy against cisplatin-resistant human ovarian cancer cells using the modified comet assay.
He H; Huang H; Yu T
Int J Radiat Biol; 2014 Oct; 90(10):897-902. PubMed ID: 24827854
[TBL] [Abstract][Full Text] [Related]
15. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
[TBL] [Abstract][Full Text] [Related]
16. Nanosecond electric pulses induce DNA breaks in cisplatin-sensitive and -resistant human ovarian cancer cells.
Linghu L; Tan Y; Lou Y; Hu L; Yang H; Yu T
Biochem Biophys Res Commun; 2013 Jan; 430(2):695-9. PubMed ID: 23211598
[TBL] [Abstract][Full Text] [Related]
17. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
Chen G; Zeller WJ
Anticancer Res; 1993; 13(1):219-23. PubMed ID: 8476216
[TBL] [Abstract][Full Text] [Related]
18. Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumor cells.
Chen G; Zeller WJ
Anticancer Res; 1994; 14(4A):1461-7. PubMed ID: 7979172
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
Zhang T; Guan M; Jin HY; Lu Y
Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
[TBL] [Abstract][Full Text] [Related]
20. Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin.
Okuda T; Lin X; Trang J; Howell SB
Mol Pharmacol; 2005 Jun; 67(6):1852-60. PubMed ID: 15758147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
